Alan Ezekowitz - Net Worth and Insider Trading
Alan Ezekowitz Net Worth
The estimated net worth of Alan Ezekowitz is at least $878,302 dollars as of 2025-05-03. Alan Ezekowitz is the Director of Septerna Inc and owns about 117,420 shares of Septerna Inc (SEPN) stock worth over $878,302. Details can be seen in Alan Ezekowitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Ezekowitz has not made any transactions after 2025-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Ezekowitz
Alan Ezekowitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Ezekowitz owns 2 companies in total, including Fulcrum Therapeutics Inc (FULC) , and Organon & Co (OGN) .
Click here to see the complete history of Alan Ezekowitz’s form 4 insider trades.
Insider Ownership Summary of Alan Ezekowitz
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2020-06-11 | director |
| OGN | Organon & Co | 2021-06-02 | director |
Alan Ezekowitz Latest Holdings Summary
Alan Ezekowitz currently owns a total of 1 stock. Alan Ezekowitz owns 117,420 shares of Septerna Inc (SEPN) as of March 7, 2025, with a value of $878,302.
Latest Holdings of Alan Ezekowitz
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SEPN | Septerna Inc | 2025-03-07 | 117,420 | 7.48 | 878,302 |
Holding Weightings of Alan Ezekowitz
Alan Ezekowitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Ezekowitz has made a total of 2 transactions in Septerna Inc (SEPN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Septerna Inc is the acquisition of 13,319 shares on March 7, 2025, which cost Alan Ezekowitz around $92,301.
Insider Trading History of Alan Ezekowitz
- 1
Alan Ezekowitz Trading Performance
GuruFocus tracks the stock performance after each of Alan Ezekowitz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan Ezekowitz is %. GuruFocus also compares Alan Ezekowitz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan Ezekowitz within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan Ezekowitz's insider trading performs compared to the benchmark.
Performance of Alan Ezekowitz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.09 |  | | | | |
| Relative Return to S&P 500(%) | -3.16 | | | | | |
Alan Ezekowitz Ownership Network
Ownership Network List of Alan Ezekowitz
Ownership Network Relation of Alan Ezekowitz
Alan Ezekowitz Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Alan Ezekowitz is the director of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Alan Ezekowitz made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,120 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,120 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,240 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Alan Ezekowitz Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Ezekowitz. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alan Ezekowitz's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
